Nanotechnology Now

Our NanoNews Digest Sponsors



Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > National Dendrimer and Nano Center Attracts Emerging Bio Lab

CMU National Dendrimer and Nanotechnology Center Attracts Emerging Biotechnology Laboratory

Posted on January 06, 2006

A company developing biotechnologies for coatings and artificial cells that may treat many health conditions is locating a laboratory at Central Michigan University.

Initially, two researchers from Connecticut-based Artificial Cell Technologies Inc. will be located in CMU's Dow Science Complex. One ACT staff person has been at CMU since last summer.

In the future, ACT will join Dendritic NanoTechnologies Inc. and MultiGEN Diagnostics Inc. in relocating to a $5 million CMU wet lab facility that is supported by a $2.15 million U.S. Department of Commerce grant, $250,000 in Michigan Economic Development Corp. funding and $2.6 million from CMU.

The company is commercializing a new nanotechnology involving designed polypeptides that may lead to treatments for many health conditions and opportunities for research for CMU faculty and students.

Using technology originally developed at Louisiana Tech University, ACT designs, characterizes and produces complex, multilayer, nano-assembled polypeptide films, coatings and microcapsules. Peptides are natural or synthetic compounds containing two or more amino acids. Polypeptides are small proteins typically containing between 10 and 100 molecules of amino acids.

Among ACT's current research and development priorities are enantioselective filter membranes for pharmaceutical research and manufacturing, coatings for cell and tissue culture, and the encapsulation of hemoglobin to make artificial red blood cells. A safe, universally transfusible artificial red blood cell with a long life span in the body would transform human health, potentially eliminating blood supply shortages while also representing a new treatment modality for chronic conditions such as congestive heart disease, microvasculature disease and long-lasting anemias such as those caused by malaria.

ACT's technology also appears well suited to development of microcapsules for systemic or targeted drug delivery with tunable timed-release and other useful medical properties, multiantigen artificial virus vaccines, biocompatible coatings for medical devices and instruments, and antimicrobial coatings for food, food packaging or clothing.

ACT Chief Scientific Officer Don Haynie said that from the time of his first visit to CMU, he has been impressed with the capabilities of CMU's faculty and students, as well as the advanced equipment and facilities. The potential for synergistic relationships with other young technology firms at CMU's National Dendrimer and Nanotechnology Center, including Dendritic Nanotechnologies and Bio-ID Diagnostic, also appeals to Haynie.

"We are excited about the opportunity to be involved in bringing new educational opportunities to CMU while also leveraging the many scientific assets available within the central Michigan community to help ACT develop and commercialize our valuable products," said Haynie.

CMU students and faculty will have the opportunity to collaborate on projects and learn new skills through hands-on research experiences, including polypeptide synthesis and purification and the design and assembly of polypeptide nanostructures.

ACT Chief Executive Officer Tom Malone said, "The potential for achieving world-leading therapeutic and industrial advancements is greatly advanced by CMU's willingness to invest time, money and energy in fostering university-private company partnerships."

Malone also credited the support and vision of top officers at the university, valuable business services from the CMU Research Corp., and lower operating costs associated with research and development activities, when compared to the East Coast.

####
CMURC Contact:
Brent Case
(989) 774-1021
brent.case@cmich.edu

ACT Contact:
Thomas Malone
(203) 402-7209

Copyright © Central Michigan University

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Possible Futures

A novel method for identifying the body’s ‘noisiest’ networks November 19th, 2014

Researchers discern the shapes of high-order Brownian motions November 17th, 2014

VDMA Electronics Production Equipment: Growth track for 2014 and 2015 confirmed: Business climate survey shows robust industry sector November 14th, 2014

Open Materials Development Will Be Key for HP's Success in 3D Printing: HP can make a big splash in 3D printing, but it needs to shore up technology claims and avoid the temptation of the razor/razor blade business model in order to flourish November 11th, 2014

Investments/IPO's/Splits

Pixelligent Closes $5.5 Million in Funding: Capital Will Be Used to Support Global Customer Growth December 12th, 2014

Nanometrics Announces Upcoming Investor Events November 19th, 2014

Eight19 secures £1m funding: Investment to develop production technology, and expand commercial activities for organic photovoltaics November 19th, 2014

Arrowhead to Present at Upcoming Conferences November 15th, 2014

Nanomedicine

Iranian Researchers Produce Electrical Pieces Usable in Human Body December 18th, 2014

Zenosense, Inc. - Hospital Collaboration - 400 Person Lung Cancer Detection Trial December 17th, 2014

Unraveling the light of fireflies December 17th, 2014

First Home-Made Edible Herbal Nanodrug Presented to Pharmacies across Iran December 17th, 2014

Materials/Metamaterials

ORNL microscopy pencils patterns in polymers at the nanoscale December 17th, 2014

Pb islands in a sea of graphene magnetise the material of the future December 16th, 2014

Graphene Applied in Production of Recyclable Electrodes December 13th, 2014

A golden thread through the labyrinth of nanomaterials December 12th, 2014

Announcements

Silicon Valley-Based Foresight Valuation Launches STR-IP™, a New Initiative for Startups to Discover the Value of Their Intellectual Property December 18th, 2014

Iranian Scientists Use Nanotechnology to Increase Power, Energy of Supercapacitors December 18th, 2014

Iranian Researchers Produce Electrical Pieces Usable in Human Body December 18th, 2014

First Home-Made Edible Herbal Nanodrug Presented to Pharmacies across Iran December 17th, 2014

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE